SCHEMBL161619

SCHEMBL161619

Cc1cn2c(CC(=O)N3CCN(c4ccccc4C(=O)Nc4ccncc4)CC3)csc2n1.O=C(Nc1ccncc1)c1ccccc1N1CCN(C(=O)Cc2cn3ccccc3n2)CC1.O=C(Nc1ccncc1)c1ccccc1N1CCN(C(=O)Cc2cn3cccnc3n2)CC1.O=C(Nc1ccncc1)c1ccccc1N1CCN(C(=O)Cc2cn3ccsc3n2)CC1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.35
KDM4E B2RXH2 5/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 3/20 0.33
TSHR P16473 2/20 0.33
TP53 P04637 3/20 0.32
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
ALDH1A1 P00352 4/20 0.31
USP2 O75604 1/20 0.31
ALOX15 P16050 1/20 0.31
MAPK1 P28482 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
EGFR P00533 1/20 0.31
ERBB2 P04626 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113374 0.82 TYK2 (0.40) MAPTKDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL167315 0.81 MAPT (0.45) MAPTKDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL157316 0.81 HPGD (0.43) MAPTKDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL163614 0.80 NPC1 (0.42) MAPTKDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL13097268 0.70 TYK2 (0.40) MAPTKDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL112720 0.66 TRPV1 (0.42) MAPTSMN1; SMN2LMNAHTTALDH1A1
SCHEMBL111377 0.66 CXCR3 (0.46) MAPTSMN1; SMN2GAALMNAHTT
SCHEMBL112787 0.66 TYK2 (0.43) MAPTSMN1; SMN2GAATSHRLMNA
SCHEMBL3105119 0.64 TRPV1 (0.50) KDM4ESMN1; SMN2GAAHTTALDH1A1
SCHEMBL114399 0.63 ALDH1A1 (0.43) MAPTKDM4EHPGDHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424858-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed